Today we talk about transmission, diagnosis and management of MPox. We will also review the UK community and the World Health’s Organization's perspective on this virus. Please note that after the recording of this podcast the WHO implemented a change of the name of the virus to MPox.Dr Fabiola Martin, STI's Podcast editor, interviews Dr Liesbeth Van Gestel, ID physician and clinical researcher at the Tropical Institute of Antwerp, Belgium; Mr Simon Collins, director and co-founder of HIV iBase London, UK; as well as Dr Meg Doherty, the World Health Organisation’s Director of Global HIV, Hepatitis and STIs Programmes.For more information, please read the STI recently published articles: one from Vanhamel and co-authors tracking the transmission of the virus in the early phases of the outbreak in Belgium (https://sti.bmj.com/content/early/2022/11/17/sextrans-2022-055601), and a second from Heskin and colleagues reporting on the rapid response of sexual health services to the outbreak in the UK (https://sti.bmj.com/content/early/2022/12/14/sextrans-2022-055558?rss=1).

Today we talk about transmission, diagnosis and management of MPox. We will also review the UK community and the World Health’s Organization's perspective on this virus. Please note that after the recording of this podcast the WHO implemented a change of the name of the virus to MPox. Dr Fabiola Martin, STI's Podcast editor, interviews Dr Liesbeth Van Gestel, ID physician and clinical researcher at the Tropical Institute of Antwerp, Belgium; Mr Simon Collins, director and co-founder of HIV iBase London, UK; as well as Dr Meg Doherty, the World Health Organisation’s Director of Global HIV, Hepatitis and STIs Programmes. For more information, please read the STI recently published articles: one from Vanhamel and co-authors tracking the transmission of the virus in the early phases of the outbreak in Belgium (<a href="https://sti.bmj.com/content/early/2022/11/17/sextrans-2022-055601" rel="nofollow" target="_blank">https://sti.bmj.com/content/early/2022/11/17/sextrans-2022-055601</a>), and a second from Heskin and colleagues reporting on the rapid response of sexual health services to the outbreak in the UK (<a href="https://sti.bmj.com/content/early/2022/12/14/sextrans-2022-055558?rss=1" rel="nofollow" target="_blank">https://sti.bmj.com/content/early/2022/12/14/sextrans-2022-055558?rss=1</a>).

MPox 101, Community and Global response

In this double-interview podcast, the Editor-in-Chief of the STI journal, Professor Anna Maria Geretti, brings you some of the highlights from the HIV Glasgow 2022 conference.In the first interview (starting at 1:00), Professor Geretti interviews Jean-Michel Molina*, who discusses HIV and STI prevention.The second interview (starting at 12:30) is with Professor Miłosz Parczewski**. They discuss the effects of the war in Ukraine on the country’s healthcare system, in particular on the prevalence of STIs.  *Professor of Infectious Diseases University of Paris, France and Head of the Infectious Diseases Department, Saint-Louis Hospital and Lariboisière Hospital Paris, France. **Clinical specialist and Professor of Infectious Diseases Pomeranian Medical University, Szczecin, Poland. Associate Editor on STI and newly elected Vice President of the European AIDS Clinical Society. To hear more episodes of the STI Podcast, please subscribe: https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980

In this double-interview podcast, the Editor-in-Chief of the STI journal, Professor Anna Maria Geretti, brings you some of the highlights from the HIV Glasgow 2022 conference. In the first interview (starting at 1:00), Professor Geretti interviews Jean-Michel Molina*, who discusses HIV and STI prevention. The second interview (starting at 12:30) is with Professor Miłosz Parczewski**. They discuss the effects of the war in Ukraine on the country’s healthcare system, in particular on the prevalence of STIs. *Professor of Infectious Diseases University of Paris, France and Head of the Infectious Diseases Department, Saint-Louis Hospital and Lariboisière Hospital Paris, France. **Clinical specialist and Professor of Infectious Diseases Pomeranian Medical University, Szczecin, Poland. Associate Editor on STI and newly elected Vice President of the European AIDS Clinical Society. To hear more episodes of the STI Podcast, please subscribe: <a href="https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980" rel="nofollow" target="_blank">https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980</a>

HIV and STI prevention, plus HIV in Ukraine

Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm. Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, based in Seattle (WA)join Dr Fabiola Martin, STI's Podcast editor, in this short interview.Please listen to a recent podcast on the wider subject of Bacterial STIs: https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/stiRelated links:https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds academic.oup.com/cid/article/70/6/1247/5557867 www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/ To hear more episodes of the STI Podcast, please subscribe: https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980

Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm. Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, based in Seattle (WA)join Dr Fabiola Martin, STI's Podcast editor, in this short interview. Please listen to a recent podcast on the wider subject of Bacterial STIs: <a href="https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/sti" rel="nofollow" target="_blank">https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/sti</a> Related links: <a href="https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds" rel="nofollow" target="_blank">https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds</a> <a href="http://academic.oup.com/cid/article/70/6/1247/5557867" rel="nofollow" target="_blank">academic.oup.com/cid/article/70/6/1247/5557867</a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/" rel="nofollow" target="_blank">www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/</a> To hear more episodes of the STI Podcast, please subscribe: <a href="https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980" rel="nofollow" target="_blank">https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980</a>

Bacterial STIs: The DoxyPEP Trial

Today we focus on presumptive and prophylactic management of bacterial STIs, talking with Dr Manoji Gunathilake, Head of sexual health services in Darwin, Australia, and Assistant Prof Will Nutland, the director of the NGO, the Love Tank, in London, UK.Related links:STI Guidelines Australia: https://sti.guidelines.org.au/The Love Tank: http://thelovetank.info/GRASP report: data to June 2021 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033882/GRASP_2020_Report.pdfTaking antibiotic after sex cuts STIs by two-thirds, ‘DoxyPEP’ study finds - www.aidsmap.com/news/jul-2022/tak…xypep-study-finds Doxycycline PEP significantly reduces STIs in people at high risk of infections - i-base.info/htb/43528

Today we focus on presumptive and prophylactic management of bacterial STIs, talking with Dr Manoji Gunathilake, Head of sexual health services in Darwin, Australia, and Assistant Prof Will Nutland, the director of the NGO, the Love Tank, in London, UK. Related links: STI Guidelines Australia: <a href="https://sti.guidelines.org.au/" rel="nofollow" target="_blank">https://sti.guidelines.org.au/</a> The Love Tank: <a href="http://thelovetank.info/" rel="nofollow" target="_blank">http://thelovetank.info/</a> GRASP report: data to June 2021 <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033882/GRASP_2020_Report.pdf" rel="nofollow" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033882/GRASP_2020_Report.pdf</a> Taking antibiotic after sex cuts STIs by two-thirds, ‘DoxyPEP’ study finds - <a href="http://www.aidsmap.com/news/jul-2022/tak…xypep-study-finds" rel="nofollow" target="_blank">www.aidsmap.com/news/jul-2022/tak…xypep-study-finds</a> Doxycycline PEP significantly reduces STIs in people at high risk of infections - <a href="http://i-base.info/htb/43528" rel="nofollow" target="_blank">i-base.info/htb/43528</a>

Presumptive and Prophylactic management of Bacterial STIs

In this podcast, we interview Professor Joel Palefsky about the ANCHOR study. Sexually Transmitted Infections' Editorial Fellow, Dr Ming Lee, speaks to the journal Editor in Chief, Professor Anna Maria Geretti, and Professor Palefsky, chief investigator of the randomised controlled trial, about the study which investigated treatment of anal high-grade squamous intraepithelial lesions (HSIL) to prevent progression to anal cancer. The study was stopped early following an interim analysis showing a clear benefit in reducing the risk of progression to anal cancer by 57 %, and the findings were recently published in the New England Journal of Medicine. Professor Palefsky also discusses how screening for anal cancer could be improved.Related link about the ANCHOR study: https://www.nejm.org/doi/10.1056/NEJMoa2201048?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed

In this podcast, we interview Professor Joel Palefsky about the ANCHOR study. Sexually Transmitted Infections' Editorial Fellow, Dr Ming Lee, speaks to the journal Editor in Chief, Professor Anna Maria Geretti, and Professor Palefsky, chief investigator of the randomised controlled trial, about the study which investigated treatment of anal high-grade squamous intraepithelial lesions (HSIL) to prevent progression to anal cancer. The study was stopped early following an interim analysis showing a clear benefit in reducing the risk of progression to anal cancer by 57 %, and the findings were recently published in the New England Journal of Medicine. Professor Palefsky also discusses how screening for anal cancer could be improved. Related link about the ANCHOR study: <a href="https://www.nejm.org/doi/10.1056/NEJMoa2201048?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed" rel="nofollow" target="_blank">https://www.nejm.org/doi/10.1056/NEJMoa2201048?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed</a>

Preventing anal cancer in people with HIV: learnings from the ANCHOR study

Thank you for joining us for the HTLV2022 Conference review. Dr Fabiola Martin speaks to Joanna Curteis, the Australian patient representative, Dr Carolina Rosadas, researcher associate at National Centre for Human Retrovirology, Imperial College London, who specialises in HTLV-1 vertical transmission and Prof Damian Purcell. Damian's research group investigates the HIV-1 and HTLV-1 human retroviruses that cause AIDS and leukaemia/inflammatory pathogenesis respectively at Doherty Institute, Melbourne. We also discuss the Global Call to Action towards the elimination of HTLV-1 and an important message from the World Health Organisation delivered by Dr Meg Doherty.Related blog post: https://blogs.bmj.com/sti/2022/07/06/ichr-2022/Related links:https://www.htlvnet.com https://www.htlvaware.com HTLV Channel https://www.youtube.com/channel/UCI6aLSTtk7chXMeybJ92Fhw Follow @HTLVChannel National Centre for Human Retrovirology http://www.htlv.eu/ WHO HTLV technical report https://apps.who.int/iris/handle/10665/339773

Thank you for joining us for the HTLV2022 Conference review. Dr Fabiola Martin speaks to Joanna Curteis, the Australian patient representative, Dr Carolina Rosadas, researcher associate at National Centre for Human Retrovirology, Imperial College London, who specialises in HTLV-1 vertical transmission and Prof Damian Purcell. Damian's research group investigates the HIV-1 and HTLV-1 human retroviruses that cause AIDS and leukaemia/inflammatory pathogenesis respectively at Doherty Institute, Melbourne. We also discuss the Global Call to Action towards the elimination of HTLV-1 and an important message from the World Health Organisation delivered by Dr Meg Doherty. Related blog post: <a href="https://blogs.bmj.com/sti/2022/07/06/ichr-2022/" rel="nofollow" target="_blank">https://blogs.bmj.com/sti/2022/07/06/ichr-2022/</a> Related links: <a href="https://www.htlvnet.com" rel="nofollow" target="_blank">https://www.htlvnet.com</a> <a href="https://www.htlvaware.com" rel="nofollow" target="_blank">https://www.htlvaware.com</a> HTLV Channel <a href="https://www.youtube.com/channel/UCI6aLSTtk7chXMeybJ92Fhw" rel="nofollow" target="_blank">https://www.youtube.com/channel/UCI6aLSTtk7chXMeybJ92Fhw</a> Follow @HTLVChannel National Centre for Human Retrovirology <a href="http://www.htlv.eu/" rel="nofollow" target="_blank">http://www.htlv.eu/</a> WHO HTLV technical report <a href="https://apps.who.int/iris/handle/10665/339773" rel="nofollow" target="_blank">https://apps.who.int/iris/handle/10665/339773</a>

HTLV2022: 20th International Conference on Human Retrovirology

In this podcast, we focus on the bacterial genitourinary pathogen Mycoplasma genitalium (MGEN). We have known this pathogen for a long-time but only in recent years we have been testing and treating more frequently for this bacteria. In this conversation with Dr Fabiola Martin, STI's Podcast editor, Dr Emma Sweeney, Prof Catriona Bradshaw and Prof Nicola Low provide a clinical and research update on MGEN. Dr Emma Sweeney is a Postdoctoral researcher, The University of Queensland Centre for Clinical Research, Brisbane, Australia. Prof Catriona Bradshaw is a Clinician researcher based at Melbourne Sexual Health Centre, Melbourne, Australia. Prof Nicola Low is an Infectious disease epidemiologist, leading the Sexual and Reproductive Health Research Group at the Institute of Social and Preventive Medicine, University of Bern, Switzerland.Read the blog post: https://blogs.bmj.com/sti/2022/04/06/mgen/Some relevant papers published by STI: Adverse pregnancy and perinatal outcomes, 2022, Frenzer C, Egli-Gany D, Vallely L, et al. https://sti.bmj.com/content/early/2022/03/28/sextrans-2021-055352 Prevalence in different populations, 2018, Baumann L, Cina M, Egli-Gany D, et al. https://sti.bmj.com/content/94/4/255 Persistence, concordance, complications in non-pregnant people, 2019, Cina M, Baumann L, Egli-Gany D, et al. https://sti.bmj.com/content/95/5/328

In this podcast, we focus on the bacterial genitourinary pathogen Mycoplasma genitalium (MGEN). We have known this pathogen for a long-time but only in recent years we have been testing and treating more frequently for this bacteria. In this conversation with Dr Fabiola Martin, STI's Podcast editor, Dr Emma Sweeney, Prof Catriona Bradshaw and Prof Nicola Low provide a clinical and research update on MGEN. Dr Emma Sweeney is a Postdoctoral researcher, The University of Queensland Centre for Clinical Research, Brisbane, Australia. Prof Catriona Bradshaw is a Clinician researcher based at Melbourne Sexual Health Centre, Melbourne, Australia. Prof Nicola Low is an Infectious disease epidemiologist, leading the Sexual and Reproductive Health Research Group at the Institute of Social and Preventive Medicine, University of Bern, Switzerland. Read the blog post: <a href="https://blogs.bmj.com/sti/2022/04/06/mgen/" rel="nofollow" target="_blank">https://blogs.bmj.com/sti/2022/04/06/mgen/</a> Some relevant papers published by STI: Adverse pregnancy and perinatal outcomes, 2022, Frenzer C, Egli-Gany D, Vallely L, et al. <a href="https://sti.bmj.com/content/early/2022/03/28/sextrans-2021-055352" rel="nofollow" target="_blank">https://sti.bmj.com/content/early/2022/03/28/sextrans-2021-055352</a> Prevalence in different populations, 2018, Baumann L, Cina M, Egli-Gany D, et al. <a href="https://sti.bmj.com/content/94/4/255" rel="nofollow" target="_blank">https://sti.bmj.com/content/94/4/255</a> Persistence, concordance, complications in non-pregnant people, 2019, Cina M, Baumann L, Egli-Gany D, et al. <a href="https://sti.bmj.com/content/95/5/328" rel="nofollow" target="_blank">https://sti.bmj.com/content/95/5/328</a>

Mycoplasma Genitalium: Easy to detect, hard to treat

Today we focus on NATSAL and NATSAL COVID. These are Britain’s National Surveys of Sexual Attitudes and Lifestyles. NATSAL has been undertaken every 10 years since 1990 and is a key data source for sexual and reproductive health policy development. However, the COVID-19 pandemic disrupted many aspects of sexual lifestyles, prompting the initiation of the NATSAL-COVID study with the aim of understanding the impact of COVID-19 on sexual behaviour and service use. Professor Cath Mercer and Professor Nigel Field join us to discuss the results of this study. All the findings relate to the first four months of lockdown in Britain, which started in March 2020.Related blog: https://blogs.bmj.com/sti/2022/02/23/natsal-covid-sex-love-and-lockdown/Relevant Natsal-COVID papers: - STI paper on sexual behaviour during the pandemic: https://sti.bmj.com/content/early/2021/12/14/sextrans-2021-055210 - Paper in Lancet PH on sexual health services: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00253-X - Paper in BMJ Open on sex outside of the household: https://bmjopen.bmj.com/content/12/2/e055284  - Natsal-COVID wave 1 method paper: https://wellcomeopenresearch.org/articles/6-209

Today we focus on NATSAL and NATSAL COVID. These are Britain’s National Surveys of Sexual Attitudes and Lifestyles. NATSAL has been undertaken every 10 years since 1990 and is a key data source for sexual and reproductive health policy development. However, the COVID-19 pandemic disrupted many aspects of sexual lifestyles, prompting the initiation of the NATSAL-COVID study with the aim of understanding the impact of COVID-19 on sexual behaviour and service use. Professor Cath Mercer and Professor Nigel Field join us to discuss the results of this study. All the findings relate to the first four months of lockdown in Britain, which started in March 2020. Related blog: <a href="https://blogs.bmj.com/sti/2022/02/23/natsal-covid-sex-love-and-lockdown/" rel="nofollow" target="_blank">https://blogs.bmj.com/sti/2022/02/23/natsal-covid-sex-love-and-lockdown/</a> Relevant Natsal-COVID papers: - STI paper on sexual behaviour during the pandemic: <a href="https://sti.bmj.com/content/early/2021/12/14/sextrans-2021-055210" rel="nofollow" target="_blank">https://sti.bmj.com/content/early/2021/12/14/sextrans-2021-055210</a> - Paper in Lancet PH on sexual health services: <a href="https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00253-X" rel="nofollow" target="_blank">https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00253-X</a> - Paper in BMJ Open on sex outside of the household: <a href="https://bmjopen.bmj.com/content/12/2/e055284" rel="nofollow" target="_blank">https://bmjopen.bmj.com/content/12/2/e055284</a> - Natsal-COVID wave 1 method paper: <a href="https://wellcomeopenresearch.org/articles/6-209" rel="nofollow" target="_blank">https://wellcomeopenresearch.org/articles/6-209</a>

NATSAL-COVID: Britain's National Surveys of Sexual Attitudes and Lifestyles

Human T

On the World HTLV Day (10th November), we focus on how the Human T leukaemia virus affects people, and review new developments in HTLV treatment and vaccination medicine. HTLV is a retrovirus similar to HIV which incorporates its DNA indefinitely into the human CD4 T lymphocytes. It is predominantly transmitted through condomless sex, but also from mother-to-child and through contact with HTLV positive blood. Unlike HIV, HTLV causes severe disease only in about 5% of PLHTLV, so it is easy for HTLV transmission to go unnoticed. The two dominant HTLV associated diseases are Adult T cell leukaemia (ATL) and HTLV-1 associated myelopathy (HAM/TSP). Participants: STI's Podcast Editor, Dr Fabiola Martin, interview Ms Kristy Blakeborough, Lived experience and UK patient rep; Prof Yoshihisa Yamano, Neurologist St Marianna University Japan; A/P Keith Chappell, University of Queensland.Read the blog post: https://blogs.bmj.com/sti/2021/11/10/world_htlv_day/Other relevant links: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2818%2930974-7/fulltext https://gvn.org/who/ https://pubmed.ncbi.nlm.nih.gov/27965813/ https://pubmed.ncbi.nlm.nih.gov/33250897/ https://www.htlvaware.com

On the World HTLV Day (10th November), we focus on how the Human T leukaemia virus affects people, and review new developments in HTLV treatment and vaccination medicine. HTLV is a retrovirus similar to HIV which incorporates its DNA indefinitely into the human CD4 T lymphocytes. It is predominantly transmitted through condomless sex, but also from mother-to-child and through contact with HTLV positive blood. Unlike HIV, HTLV causes severe disease only in about 5% of PLHTLV, so it is easy for HTLV transmission to go unnoticed. The two dominant HTLV associated diseases are Adult T cell leukaemia (ATL) and HTLV-1 associated myelopathy (HAM/TSP). Participants: STI's Podcast Editor, Dr Fabiola Martin, interview Ms Kristy Blakeborough, Lived experience and UK patient rep; Prof Yoshihisa Yamano, Neurologist St Marianna University Japan; A/P Keith Chappell, University of Queensland. Read the blog post: <a href="https://blogs.bmj.com/sti/2021/11/10/world_htlv_day/" rel="nofollow" target="_blank">https://blogs.bmj.com/sti/2021/11/10/world_htlv_day/</a> Other relevant links: <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2818%2930974-7/fulltext" rel="nofollow" target="_blank">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2818%2930974-7/fulltext</a> <a href="https://gvn.org/who/" rel="nofollow" target="_blank">https://gvn.org/who/</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27965813/" rel="nofollow" target="_blank">https://pubmed.ncbi.nlm.nih.gov/27965813/</a> <a href="https://pubmed.ncbi.nlm.nih.gov/33250897/" rel="nofollow" target="_blank">https://pubmed.ncbi.nlm.nih.gov/33250897/</a> <a href="https://www.htlvaware.com" rel="nofollow" target="_blank">https://www.htlvaware.com</a>

World Human T Leukaemia Virus Day: patient, clinician and scientist's perspectives

In this podcast we discuss the reported impact of HIV infection on people who are hospitalised with COVID-19, by reviewing three publications: 1. Outcomes of COVID-19 Related Hospitalization Among People With HIV in the ISARIC WHO Clinical Characterization Protocol: A Prospective Observational Study. Clinical Infectious Diseases, 23 October 2020 (https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-HIV-2021).2.Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis.Nature, Scientific Reports, 18 March 2021 (https://www.nature.com/articles/s41598-021-85359-3). 3. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS has just been released. WHO Global Clinical Platform, 15 July 2021 (https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1605/5937133).STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; and Associated Research Professor Dr Paddy Ssentongo, from the Penn State University, Pennsylvania, USA.Read the blog post: https://blogs.bmj.com/sti/2021/09/16/c19-plwh-revisited/

In this podcast we discuss the reported impact of HIV infection on people who are hospitalised with COVID-19, by reviewing three publications: 1. Outcomes of COVID-19 Related Hospitalization Among People With HIV in the ISARIC WHO Clinical Characterization Protocol: A Prospective Observational Study. Clinical Infectious Diseases, 23 October 2020 (<a href="https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-HIV-2021" rel="nofollow" target="_blank">https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-HIV-2021</a>). 2.Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis.Nature, Scientific Reports, 18 March 2021 (<a href="https://www.nature.com/articles/s41598-021-85359-3" rel="nofollow" target="_blank">https://www.nature.com/articles/s41598-021-85359-3</a>). 3. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS has just been released. WHO Global Clinical Platform, 15 July 2021 (<a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1605/5937133" rel="nofollow" target="_blank">https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1605/5937133</a>). STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; and Associated Research Professor Dr Paddy Ssentongo, from the Penn State University, Pennsylvania, USA. Read the blog post: <a href="https://blogs.bmj.com/sti/2021/09/16/c19-plwh-revisited/" rel="nofollow" target="_blank">https://blogs.bmj.com/sti/2021/09/16/c19-plwh-revisited/</a>

Impact of HIV infection on COVID-19 clinical outcome

From June 2023, all our podcasts will move to https://stibmj.podbean.com.You can continue with your subscription on your favourite podcast App.Sexually Transmitted Infections is the world's longest running international journal on sexual health. It aims to keep practitioners, trainees and researchers up to date in the prevention, diagnosis and treatment of all STIs and HIV. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

From June 2023, all our podcasts will move to <a href="https://stibmj.podbean.com" rel="nofollow" target="_blank">https://stibmj.podbean.com</a>. You can continue with your subscription on your favourite podcast App. Sexually Transmitted Infections is the world's longest running international journal on sexual health. It aims to keep practitioners, trainees and researchers up to date in the prevention, diagnosis and treatment of all STIs and HIV. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

STI podcast

How does drug use feed into STI transmission in men who have sex with men? What kinds of behaviours happen, and how can clinicians discuss these issues with men and best help them?In this podcast Adam Bourne, London School of Hygiene &amp; Tropical Medicine, and David Stuart, substance use lead at the 56 Dean Street sexual health clinic, discuss the issues and offer their advice.Read the related article:Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study http://goo.gl/u6xubb

How does drug use feed into STI transmission in men who have sex with men? What kinds of behaviours happen, and how can clinicians discuss these issues with men and best help them? In this podcast Adam Bourne, London School of Hygiene &amp; Tropical Medicine, and David Stuart, substance use lead at the 56 Dean Street sexual health clinic, discuss the issues and offer their advice. Read the related article: Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study <a href="http://goo.gl/u6xubb" rel="nofollow" target="_blank">http://goo.gl/u6xubb</a>

Sex, drugs, and men who have sex with men

In this episode of the STI podcast, Richard Crosby from the University of Kentucky talks to Mary Ott from Indiana University about her research on condom use, and attitudes towards, in 14-16 year-old boys.Read the article online: http://tinyurl.com/atc2rah

In this episode of the STI podcast, Richard Crosby from the University of Kentucky talks to Mary Ott from Indiana University about her research on condom use, and attitudes towards, in 14-16 year-old boys.Read the article online: <a href="http://tinyurl.com/atc2rah" rel="nofollow" target="_blank">http://tinyurl.com/atc2rah</a>

STI podcast: Condom use and attitudes in teenage boys

Two women die a week in consequence of domestic violence and abuse in the UK. It is increasingly recognised that enquiry by healthcare practitioners can enable pathways to earlier intervention and support. Editor-in-Chief of Sexually Transmitted Infections, Jackie Cassell, is joined by two specialists in the field to discuss the special issue of the journal on domestic and intimate partner violence, published in March 2018: http://sti.bmj.com/content/94/2.Neha Pathak (Wellcome Trust Clinical PhD Fellow, Institute for Epidemiology &amp; Healthcare, University College London) and Gene Feder (University of Bristol, Centre for Academic Primary Care) discuss the various forms of the abuse and how healthcare practitioners can intervene.Related papers discussed in this podcast: - Highlights from this issue - http://sti.bmj.com/content/94/2/79 - Editorial: Routine enquiry for domestic violence and abuse in sexual health settings - http://sti.bmj.com/content/94/2/81 - Improving the healthcare response to domestic violence and abuse in sexual health clinics: feasibility study of a training, support and referral intervention - http://sti.bmj.com/content/94/2/83 - Assessing for domestic violence in sexual health environments: a qualitative study - http://sti.bmj.com/content/94/2/88 - Sexual relationships, intimate partner violence and STI partner notification in Cape Town, South Africa: an observational study - http://sti.bmj.com/content/94/2/144

Two women die a week in consequence of domestic violence and abuse in the UK. It is increasingly recognised that enquiry by healthcare practitioners can enable pathways to earlier intervention and support. Editor-in-Chief of Sexually Transmitted Infections, Jackie Cassell, is joined by two specialists in the field to discuss the special issue of the journal on domestic and intimate partner violence, published in March 2018: <a href="http://sti.bmj.com/content/94/2" rel="nofollow" target="_blank">http://sti.bmj.com/content/94/2</a>. Neha Pathak (Wellcome Trust Clinical PhD Fellow, Institute for Epidemiology &amp; Healthcare, University College London) and Gene Feder (University of Bristol, Centre for Academic Primary Care) discuss the various forms of the abuse and how healthcare practitioners can intervene. Related papers discussed in this podcast: - Highlights from this issue - <a href="http://sti.bmj.com/content/94/2/79" rel="nofollow" target="_blank">http://sti.bmj.com/content/94/2/79</a> - Editorial: Routine enquiry for domestic violence and abuse in sexual health settings - <a href="http://sti.bmj.com/content/94/2/81" rel="nofollow" target="_blank">http://sti.bmj.com/content/94/2/81</a> - Improving the healthcare response to domestic violence and abuse in sexual health clinics: feasibility study of a training, support and referral intervention - <a href="http://sti.bmj.com/content/94/2/83" rel="nofollow" target="_blank">http://sti.bmj.com/content/94/2/83</a> - Assessing for domestic violence in sexual health environments: a qualitative study - <a href="http://sti.bmj.com/content/94/2/88" rel="nofollow" target="_blank">http://sti.bmj.com/content/94/2/88</a> - Sexual relationships, intimate partner violence and STI partner notification in Cape Town, South Africa: an observational study - <a href="http://sti.bmj.com/content/94/2/144" rel="nofollow" target="_blank">http://sti.bmj.com/content/94/2/144</a>

Domestic violence affects a quarter of UK women: the role of sexual health practitioners

Gary Brook and Khalil Ghanem discuss a case report of syphilis uncovering drug resistance in HIV published in the journal STI.

Gary Brook and Khalil Ghanem discuss a case report of syphilis uncovering drug resistance in HIV published in the journal STI.

STI podcast: Syphilis in HIV

Cathy Ison (director of the Sexually Transmitted Bacteria Reference Laboratory, HPA) talks to David Barlow (consultant physician at the Department of Genito-Urinary Medicine, St Thomas’ Hospital) about the future of treating and testing for gonorrhoea.

Cathy Ison (director of the Sexually Transmitted Bacteria Reference Laboratory, HPA) talks to David Barlow (consultant physician at the Department of Genito-Urinary Medicine, St Thomas’ Hospital) about the future of treating and testing for gonorrhoea.

STI podcast: Treating and testing for gonorrhoea

Candida Glabrata

In this podcast we’ll be looking at chronic candida glabrata infection, discussing the reliability of STI testing on the internet, and looking at the set of standards set for all UK STI clinics.Firstly, David White and Janet Wilson discuss the formulation of treatment for chronic non-albicans vaginal candidiasis.Also, there has been an explosion in the number of websites offering STI testing - Charlotte Kent and Charlotte Gaydos discuss the relative merits of this, and the possible future of internet testing.Finally, the UK has published standards of care for all STI clinics. Christopher Fairley and Celia Skinner discuss the implementation of the document, and the merits of the approach.See also;Prevalence and management of non-albicans vaginal candidiasis - http://tinyurl.com/azmqcf4Utilising the internet to test for sexually transmitted infections: results of a survey and accuracy testing - http://tinyurl.com/b7f7apwNational Standards for the Management of Sexually Transmitted Infections: will they have an impact? - http://tinyurl.com/bdshuy7

In this podcast we’ll be looking at chronic candida glabrata infection, discussing the reliability of STI testing on the internet, and looking at the set of standards set for all UK STI clinics.Firstly, David White and Janet Wilson discuss the formulation of treatment for chronic non-albicans vaginal candidiasis.Also, there has been an explosion in the number of websites offering STI testing - Charlotte Kent and Charlotte Gaydos discuss the relative merits of this, and the possible future of internet testing.Finally, the UK has published standards of care for all STI clinics. Christopher Fairley and Celia Skinner discuss the implementation of the document, and the merits of the approach.See also;Prevalence and management of non-albicans vaginal candidiasis - <a href="http://tinyurl.com/azmqcf4" rel="nofollow" target="_blank">http://tinyurl.com/azmqcf4</a>Utilising the internet to test for sexually transmitted infections: results of a survey and accuracy testing - <a href="http://tinyurl.com/b7f7apw" rel="nofollow" target="_blank">http://tinyurl.com/b7f7apw</a>National Standards for the Management of Sexually Transmitted Infections: will they have an impact? - <a href="http://tinyurl.com/bdshuy7" rel="nofollow" target="_blank">http://tinyurl.com/bdshuy7</a>

STI podcast: Candida glabrata, internet testing, and minimum standards

Prevalence studies indicate approximately 10% of patients in HIV clinics may be infected with Neisseria gonorrhoeae (NG) and/or Chlamydia trachomatis (CT) at any given time, and a study recently published in STI by Burchell and colleagues reveals that a modest increase in testing in their clinic did not improve detection of CT and NG.Khalil Ghanem, STI associate editor, asks Stephen Berry, Division of Infectious Diseases, Johns Hopkins University School of Medicine, to comment on the paper and what can be done to improve detection of NG and CT.Read Dr Berry's full editorial: http://goo.gl/ABefHz Read Burchell et al's paper: Modest rise in chlamydia and gonorrhoea testing did not increase case detection in a clinical HIV cohort in Ontario, Canada http://goo.gl/JPsp2e

Prevalence studies indicate approximately 10% of patients in HIV clinics may be infected with Neisseria gonorrhoeae (NG) and/or Chlamydia trachomatis (CT) at any given time, and a study recently published in STI by Burchell and colleagues reveals that a modest increase in testing in their clinic did not improve detection of CT and NG. Khalil Ghanem, STI associate editor, asks Stephen Berry, Division of Infectious Diseases, Johns Hopkins University School of Medicine, to comment on the paper and what can be done to improve detection of NG and CT. Read Dr Berry's full editorial: <a href="http://goo.gl/ABefHz" rel="nofollow" target="_blank">http://goo.gl/ABefHz</a> Read Burchell et al's paper: Modest rise in chlamydia and gonorrhoea testing did not increase case detection in a clinical HIV cohort in Ontario, Canada <a href="http://goo.gl/JPsp2e" rel="nofollow" target="_blank">http://goo.gl/JPsp2e</a>

Gonorrhoea and chlamydia screening in HIV clinics: time for new tools and targets

Nicola Low, Professor of Epidemiology and Public Health at the Institute of Social and Preventive Medicine, University of Bern, Switzerland, talks to Tom Edge, writer of the Channel 4 sitcom Scrotal Recall, a drama where a young man explores his past relationships via contact tracing after discovering he has chlamydia.Tom discusses the medicine and research behind the writing, and the tensions between storytelling and science.

Nicola Low, Professor of Epidemiology and Public Health at the Institute of Social and Preventive Medicine, University of Bern, Switzerland, talks to Tom Edge, writer of the Channel 4 sitcom Scrotal Recall, a drama where a young man explores his past relationships via contact tracing after discovering he has chlamydia. Tom discusses the medicine and research behind the writing, and the tensions between storytelling and science.

Scrotal recall

Dr James Bingham, regarded by many as a father figure of the modern speciality,  tells Lt Col Ngozi Dufty about the beginning of the field of venereal disease in the UK and how the origins of the sexual health service developed in consequence of the need to protect the health of the military troops first, and then the general population as a result.This interview is one of two podcasts published by the Sexually Transmitted Infections journal to signal the Centenary of the Venereal Disease Act 1917. Read all the articles here:http://sti.bmj.com/pages/bashh-centenary-of-the-venereal-disease-act-1917.

Dr James Bingham, regarded by many as a father figure of the modern speciality, tells Lt Col Ngozi Dufty about the beginning of the field of venereal disease in the UK and how the origins of the sexual health service developed in consequence of the need to protect the health of the military troops first, and then the general population as a result. This interview is one of two podcasts published by the Sexually Transmitted Infections journal to signal the Centenary of the Venereal Disease Act 1917. Read all the articles here: <a href="http://sti.bmj.com/pages/bashh-centenary-of-the-venereal-disease-act-1917" rel="nofollow" target="_blank">http://sti.bmj.com/pages/bashh-centenary-of-the-venereal-disease-act-1917</a>.

A century of military sexual health: the origins of the speciality of venereal disease

Dr. George Kinghorn, genitourinary medicine physician with 35 years' experience, talks to Dr. Maryam Shahmanesh (Consultant and Senior Lecturer at the University College London and Mortimer Market Centre) about the “dramatic changes” introduced in the treatment of STIs with the Venereal Disease Act 1917.Professor George Kinghorn also analyses how the effects of the easier access to travel, the introduction of the contraceptive pill and the decriminalisation of homosexuality lead to a “rapid increase in the number of sexually transmitted infections” in the last 40 years and which translated into an increasing need for specialists. Commenting on the particular case of the UK, Dr Kinghorn advocates the need for specialised services in the NHS, saying that an “urgent access to [STI clinics] services is essential to preserve low-cost control of STIs”. He also looks to the main future challenges in this medical field.The interview is one of two podcasts published by the Sexually Transmitted Infections journal to signal the Centenary of the Venereal Disease Act 1917. Read all the articles here:http://sti.bmj.com/pages/bashh-centenary-of-the-venereal-disease-act-1917.

Dr. George Kinghorn, genitourinary medicine physician with 35 years' experience, talks to Dr. Maryam Shahmanesh (Consultant and Senior Lecturer at the University College London and Mortimer Market Centre) about the “dramatic changes” introduced in the treatment of STIs with the Venereal Disease Act 1917. Professor George Kinghorn also analyses how the effects of the easier access to travel, the introduction of the contraceptive pill and the decriminalisation of homosexuality lead to a “rapid increase in the number of sexually transmitted infections” in the last 40 years and which translated into an increasing need for specialists. Commenting on the particular case of the UK, Dr Kinghorn advocates the need for specialised services in the NHS, saying that an “urgent access to [STI clinics] services is essential to preserve low-cost control of STIs”. He also looks to the main future challenges in this medical field. The interview is one of two podcasts published by the Sexually Transmitted Infections journal to signal the Centenary of the Venereal Disease Act 1917. Read all the articles here: <a href="http://sti.bmj.com/pages/bashh-centenary-of-the-venereal-disease-act-1917" rel="nofollow" target="_blank">http://sti.bmj.com/pages/bashh-centenary-of-the-venereal-disease-act-1917</a>.

How we treat STIs: Centenary of The Venereal Disease Act

How can burdens and trends of gonorrhoea and syphilis be estimated using surveillance data routinely collected in low- and middle-income countries?Eline Korenromp, epidemiologist from the Avenir Health, Geneva, Switzerland, tells STI Editor Jackie Cassell how the Spectrum-STI tool, developed at request of the World Health Organization, facilitates standardised, country-level estimation of trends in adult prevalence of sexually transmitted infections.The Spectrum-STI is an epidemiological framework which facilitates data review, validation and strategic analysis, prioritisation of data collection needs and surveillance strengthening by national experts. It has so far been applied in Zimbabwe, Morocco and Mongolia. Read the full details of the study, “Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016”, on the STI website (http://dx.doi.org/10.1136/sextrans-2016-052953).

How can burdens and trends of gonorrhoea and syphilis be estimated using surveillance data routinely collected in low- and middle-income countries? Eline Korenromp, epidemiologist from the Avenir Health, Geneva, Switzerland, tells STI Editor Jackie Cassell how the Spectrum-STI tool, developed at request of the World Health Organization, facilitates standardised, country-level estimation of trends in adult prevalence of sexually transmitted infections. The Spectrum-STI is an epidemiological framework which facilitates data review, validation and strategic analysis, prioritisation of data collection needs and surveillance strengthening by national experts. It has so far been applied in Zimbabwe, Morocco and Mongolia. Read the full details of the study, “Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016”, on the STI website (<a href="http://dx.doi.org/10.1136/sextrans-2016-052953" rel="nofollow" target="_blank">http://dx.doi.org/10.1136/sextrans-2016-052953</a>).

The Spectrum-STI model: gonorrhoea and syphilis prevalence trends in low and middle-income countries

Audit vs. Quality Improvement Methodology. How to undertake quality improvement and integrate it into GUM and HIV services?Hanna Bos, from the Municipal Health Service of Deventer, The Netherlands, discusses with Anna Hartley, one of the authors of a article, which explores the premise that true quality improvement methodology is poorly understood and poorly used in the NHS. Dr. Hartley, from the Ambrose King Centre, Barts Health NHS Trust, London, UK, brings some examples to the discussion to illustrate why audits alone cannot bring about continual improvement. "How to integrate quality improvement into GUM and HIV services" is the title of the study that can be found here: http://sti.bmj.com/content/early/2016/08/22/sextrans-2016-052732.

Audit vs. Quality Improvement Methodology. How to undertake quality improvement and integrate it into GUM and HIV services? Hanna Bos, from the Municipal Health Service of Deventer, The Netherlands, discusses with Anna Hartley, one of the authors of a article, which explores the premise that true quality improvement methodology is poorly understood and poorly used in the NHS. Dr. Hartley, from the Ambrose King Centre, Barts Health NHS Trust, London, UK, brings some examples to the discussion to illustrate why audits alone cannot bring about continual improvement. "How to integrate quality improvement into GUM and HIV services" is the title of the study that can be found here: <a href="http://sti.bmj.com/content/early/2016/08/22/sextrans-2016-052732" rel="nofollow" target="_blank">http://sti.bmj.com/content/early/2016/08/22/sextrans-2016-052732</a>.

How to integrate quality improvement into GUM and HIV services

In this podcast, Jackie Cassell, the Editor in Chief of STI, talks to Anatole Menon-Johansson, from the Department of Sexual Health, Guy's &amp; St Thomas’ NHS Foundation Trust, London, UK, about partner notification technologies.The STI blog post "Improving Partner Notification with a new online tool from SXT Health CIC [Community Interest Company]" is the starting point for a broad conversation about why is partner notification on STIs so important, what's the tool about and what the future holds in the digital era.  Read the blog post here: http://blogs.bmj.com/sti/2016/05/05/improving-partner-notification-with-a-new-online-tool-from-sxt-health-cic-from-anatole-menon-johansson/.On the STI website: - Claudia Estcourt study on Accelerated Partner Treatment for primary care: http://sti.bmj.com/content/91/8/548.full.pdf+html?sid=17d93526-4a85-4ae6-a34b-7a603dd67873. - Hannelore Götz study of an online partner notification tool: "Initial evaluation of use of an online partner notification tool for STI, called ‘suggest a test’: a cross sectional pilot study", http://sti.bmj.com/content/90/3/195.abstract.

In this podcast, Jackie Cassell, the Editor in Chief of STI, talks to Anatole Menon-Johansson, from the Department of Sexual Health, Guy's &amp; St Thomas’ NHS Foundation Trust, London, UK, about partner notification technologies. The STI blog post "Improving Partner Notification with a new online tool from SXT Health CIC [Community Interest Company]" is the starting point for a broad conversation about why is partner notification on STIs so important, what's the tool about and what the future holds in the digital era. Read the blog post here: <a href="http://blogs.bmj.com/sti/2016/05/05/improving-partner-notification-with-a-new-online-tool-from-sxt-health-cic-from-anatole-menon-johansson/" rel="nofollow" target="_blank">http://blogs.bmj.com/sti/2016/05/05/improving-partner-notification-with-a-new-online-tool-from-sxt-health-cic-from-anatole-menon-johansson/</a>. On the STI website: - Claudia Estcourt study on Accelerated Partner Treatment for primary care: <a href="http://sti.bmj.com/content/91/8/548.full.pdf+html?sid=17d93526-4a85-4ae6-a34b-7a603dd67873" rel="nofollow" target="_blank">http://sti.bmj.com/content/91/8/548.full.pdf+html?sid=17d93526-4a85-4ae6-a34b-7a603dd67873</a>. - Hannelore Götz study of an online partner notification tool: "Initial evaluation of use of an online partner notification tool for STI, called ‘suggest a test’: a cross sectional pilot study", <a href="http://sti.bmj.com/content/90/3/195.abstract" rel="nofollow" target="_blank">http://sti.bmj.com/content/90/3/195.abstract</a>.

Digital tools: the future for partner notifications?

Ocular Syphilis

In this podcast, Dr Khalil Ghanem discusses ocular syphilis with the authors of two studies. Dr Susan Tuddenham, from the Johns Hopkins University in Baltimore, Maryland, USA, is the author of 'Increasing Case Reports of Ocular Syphilis in the United States: An Opportunity to Address Important Unanswered Questions', accessible here: http://goo.gl/cPcbLM and Dr Motoyuki Tsuboi, from the AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, is the author of 'Prognosis of ocular syphilis in HIV-infected patients in the antiretroviral therapy era': http://goo.gl/giAx9s .

In this podcast, Dr Khalil Ghanem discusses ocular syphilis with the authors of two studies. Dr Susan Tuddenham, from the Johns Hopkins University in Baltimore, Maryland, USA, is the author of 'Increasing Case Reports of Ocular Syphilis in the United States: An Opportunity to Address Important Unanswered Questions', accessible here: <a href="http://goo.gl/cPcbLM" rel="nofollow" target="_blank">http://goo.gl/cPcbLM</a> and Dr Motoyuki Tsuboi, from the AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, is the author of 'Prognosis of ocular syphilis in HIV-infected patients in the antiretroviral therapy era': <a href="http://goo.gl/giAx9s" rel="nofollow" target="_blank">http://goo.gl/giAx9s</a> .

Ocular Syphilis: Unanswered Questions and the Role of HIV Co-Infection

A lot has changed since the last study among shipboard populations has been conducted, about 20 years ago. What is the health of shipboard military personnel and why is it important to study their sexual health? How is life in a deployment? How can the findings of this study apply to civilian populations?  In this podcast, Judith Harbertson of San Diego State University and US Military HIV Research Program talks to Tom Nadarzynski, Brighton and Sussex Medical School, about these questions and the main conclusions of the study. Read the related article:Sexually transmitted infections and sexual behaviour of deploying shipboard US military personnel: a cross-sectional analysisgoo.gl/5GPm2D

A lot has changed since the last study among shipboard populations has been conducted, about 20 years ago. What is the health of shipboard military personnel and why is it important to study their sexual health? How is life in a deployment? How can the findings of this study apply to civilian populations? In this podcast, Judith Harbertson of San Diego State University and US Military HIV Research Program talks to Tom Nadarzynski, Brighton and Sussex Medical School, about these questions and the main conclusions of the study. Read the related article: Sexually transmitted infections and sexual behaviour of deploying shipboard US military personnel: a cross-sectional analysis <a href="http://goo.gl/5GPm2D" rel="nofollow" target="_blank">goo.gl/5GPm2D</a>

Sexual life of deploying US military shipboard populations

In this podcast Dr Katy Turner talks to Dr Vincent Cornelisse about his recently published paper "Summer Heat: A cross-sectional analysis of seasonal differences in sexual behaviour and sexually transmissible diseases in Melbourne, Australia".They discuss the seasonal differences in sexual activity and disease transmission across different sexual pairings and the seasons. Full text: http://sti.bmj.com/content/early/2015/11/05/sextrans-2015-052225.full?sid=1b9dd132-b40c-4e25-afb6-995380d28d03

In this podcast Dr Katy Turner talks to Dr Vincent Cornelisse about his recently published paper "Summer Heat: A cross-sectional analysis of seasonal differences in sexual behaviour and sexually transmissible diseases in Melbourne, Australia". They discuss the seasonal differences in sexual activity and disease transmission across different sexual pairings and the seasons. Full text: <a href="http://sti.bmj.com/content/early/2015/11/05/sextrans-2015-052225.full?sid=1b9dd132-b40c-4e25-afb6-995380d28d03" rel="nofollow" target="_blank">http://sti.bmj.com/content/early/2015/11/05/sextrans-2015-052225.full?sid=1b9dd132-b40c-4e25-afb6-995380d28d03</a>

Seasonal differences in sexual behaviour and sexually transmissible diseases in Melbourne, Australia

STI associate editor Katy Turner talks to Kyle Jones, Infection &amp; Population Health, University College London, about his studying examining who in the UK pays for sex.

STI associate editor Katy Turner talks to Kyle Jones, Infection &amp; Population Health, University College London, about his studying examining who in the UK pays for sex.

The prevalence of and factors associated with paying for sex among men resident in Britain

Jennifer Smith, STI associate editor, talks to Matthew Schabath, H. Lee Moffitt Cancer Center &amp; Research Institute, US, about his paper: Alcohol consumption and prevalence of human papillomavirus infection among US men in the HIM (HPV in Men) Study http://goo.gl/kVaHcm

Jennifer Smith, STI associate editor, talks to Matthew Schabath, H. Lee Moffitt Cancer Center &amp; Research Institute, US, about his paper: Alcohol consumption and prevalence of human papillomavirus infection among US men in the HIM (HPV in Men) Study <a href="http://goo.gl/kVaHcm" rel="nofollow" target="_blank">http://goo.gl/kVaHcm</a>

Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men

Dr Clare Tanton, UCL's Centre for Sexual Health and HIV research, and Soazig Clifton, NatCen Social Research, both researchers on The National Survey of Sexual Attitudes and Lifestyles (http://natsal.ac.uk) join us to discuss the survey, how it was carried out, and some of the reaction to their findings.Read the papers online:What's new about Natsal-3: http://goo.gl/IDaRYNConsistency in reporting sensitive sexual behaviours in Britain: http://goo.gl/Zu5qzcMethodology of Natsal-3: http://goo.gl/y85Aw6

Dr Clare Tanton, UCL's Centre for Sexual Health and HIV research, and Soazig Clifton, NatCen Social Research, both researchers on The National Survey of Sexual Attitudes and Lifestyles (<a href="http://natsal.ac.uk" rel="nofollow" target="_blank">http://natsal.ac.uk</a>) join us to discuss the survey, how it was carried out, and some of the reaction to their findings.Read the papers online:What's new about Natsal-3: <a href="http://goo.gl/IDaRYN" rel="nofollow" target="_blank">http://goo.gl/IDaRYN</a>Consistency in reporting sensitive sexual behaviours in Britain: <a href="http://goo.gl/Zu5qzc" rel="nofollow" target="_blank">http://goo.gl/Zu5qzc</a>Methodology of Natsal-3: <a href="http://goo.gl/y85Aw6" rel="nofollow" target="_blank">http://goo.gl/y85Aw6</a>

The third National Survey of Sexual Attitudes and Lifestyles in the UK

Barbara Van Der Pol, Associate Professor of Medicine, University of Alabama at Birmingham, and Dermot Hurly and Monika Buehrer-Skinner, both Anton Breinl Centre for Public Health and Tropical Medicine, James Cook University, have a conversation about issues related to chlamydia point-of-care tests and the need to continually assess the performance of these assays in real-use settings.Read the full paper here: bit.ly/1nizXj5

Barbara Van Der Pol, Associate Professor of Medicine, University of Alabama at Birmingham, and Dermot Hurly and Monika Buehrer-Skinner, both Anton Breinl Centre for Public Health and Tropical Medicine, James Cook University, have a conversation about issues related to chlamydia point-of-care tests and the need to continually assess the performance of these assays in real-use settings.Read the full paper here: <a href="http://bit.ly/1nizXj5" rel="nofollow" target="_blank">bit.ly/1nizXj5</a>

Chlamydia point-of-care tests in a tropical, low-resource setting

What is this?
1 quote, 3 ideas & 1 question from a carefully curated podcast episode.
Every Monday & Wednesday.

Want a 3rd insight and episode every week? Email me at curation@owltail.com.

OwlTail

OwlTail 1-3-1

The best podcast episodes on Startups. For anyone working in a startup, or anyone interested in the incredible stories behind how people built companies like Instagram, and Facebook. Offering both practical advice and insights, as well as the stories for how many of the biggest startups got to where they are today. Add episodes you're interested into your queue below!